Zoetis reported $9.52B of revenue over the trailing twelve months, +1.5% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $9.52B (to Q2 2026). Net Income: $2.62B, trailing twelve months to Q2 2026. Free Cash Flow: $2.32B, trailing twelve months to Q2 2026. EPS: $6.07, trailing twelve months to Q2 2026.

ZTSZoetis

HealthcareUSD

$77.53

$72.6352 weeks$154.88

ZTS as reported

Zoetis reported $9.52B of revenue over the trailing twelve months, +1.5% on the year before. 11 reported series are charted on this page, each one as filed.

$9.52B

Revenue, trailing twelve months · to Q2 2026 · +1.5% against the twelve months before

Net Income: $2.62B
Net Income · +0.96% year on year · trailing twelve months to Q2 2026
Free Cash Flow: $2.32B
Free Cash Flow · +2.1% year on year · trailing twelve months to Q2 2026
EPS: $6.07
EPS · +5.4% year on year · trailing twelve months to Q2 2026

Every series Ryufin has for ZTS, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$9.52B	+1.5%	Q2 2026
Net Income	$2.62B	+0.96%	Q2 2026
EPS	$6.07	+5.4%	Q2 2026
Gross Margin	72%	n/a	Q2 2026
Op Margin	30%	n/a	Q4 2019 · 26 quarters behind
Net Margin	27%	n/a	Q2 2026
ROE	73%	n/a	Q2 2026
ROA	17%	n/a	Q2 2026
ROIC	20%	n/a	Q4 2019 · 26 quarters behind
Free Cash Flow	$2.32B	+2.1%	Q2 2026
P/E	12.8	n/a	today